Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Fortunato Morabito; Giovanni Tripepi; Giovanni Del Poeta; Francesca Romana Mauro; Gianluigi Reda; Paolo Sportoletti; Luca Laurenti; Marta Coscia; Yair Herishanu; Marzia Varettoni; Roberta Murru; Annalisa Chiarenza; Andrea Visentin; Adalgisa Condoluci; Riccardo Moia; Daniela Pietrasanta; Giacomo Loseto; Ugo Consoli; Ilaria Scortechini; Francesca Maria Rossi; Antonella Zucchetto; Ernesto Vigna; Enrica Antonia Martino; Francesco Mendicino; Cirino Botta; Daniele Caracciolo; Ramona Cassin; Graziella D'Arrigo; Sara Galimberti; Angela Rago; Ilaria Angeletti; Annalisa Biagi; Ilaria Del Giudice; Riccardo Bomben; Antonino Neri; Gilberto Fronza; Giovanna Cutrona; Davide Rossi; Francesco Di Raimondo; Antonio Cuneo; Gianluca Gaidano; Aaron Polliack; Livio Trentin; Robin Foà; Manlio Ferrarini; Valter Gattei; Massimo Gentile

doi:10.1002/ajh.26127

Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Maria RossiAntonella Zucchetto, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Daniele Caracciolo, Ramona Cassin, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	E168-E171
Journal	American Journal of Hematology
Volume	96
Issue number	5
DOIs	https://doi.org/10.1002/ajh.26127
Publication status	Published - May 1 2021

Keywords

Adenine/analogs & derivatives
Aged
Antineoplastic Agents/therapeutic use
Datasets as Topic/statistics & numerical data
Female
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
Male
Middle Aged
Multicenter Studies as Topic
Piperidines/therapeutic use
Prognosis
Progression-Free Survival
Proportional Hazards Models
Protein Kinase Inhibitors/therapeutic use
Reproducibility of Results
Retrospective Studies
Risk Assessment
Severity of Illness Index
Survival Analysis

Access to Document

10.1002/ajh.26127

Cite this

Morabito, F., Tripepi, G., Del Poeta, G., Mauro, F. R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Varettoni, M., Murru, R., Chiarenza, A., Visentin, A., Condoluci, A., Moia, R., Pietrasanta, D., Loseto, G., Consoli, U., Scortechini, I., ... Gentile, M. (2021). Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American Journal of Hematology, 96(5), E168-E171. https://doi.org/10.1002/ajh.26127

Morabito, F, Tripepi, G, Del Poeta, G, Mauro, FR, Reda, G, Sportoletti, P, Laurenti, L, Coscia, M, Herishanu, Y, Varettoni, M, Murru, R, Chiarenza, A, Visentin, A, Condoluci, A, Moia, R, Pietrasanta, D, Loseto, G, Consoli, U, Scortechini, I, Rossi, FM , Zucchetto, A, Vigna, E, Martino, EA, Mendicino, F, Botta, C, Caracciolo, D, Cassin, R, D'Arrigo, G, Galimberti, S, Rago, A, Angeletti, I, Biagi, A, Del Giudice, I, Bomben, R , Neri, A , Fronza, G , Cutrona, G, Rossi, D, Di Raimondo, F, Cuneo, A, Gaidano, G, Polliack, A, Trentin, L, Foà, R, Ferrarini, M, Gattei, V & Gentile, M 2021, 'Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study', American Journal of Hematology, vol. 96, no. 5, pp. E168-E171. https://doi.org/10.1002/ajh.26127

@article{2d8c9e8dfca5425e957c89c9433549be,

title = "Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study",

keywords = "Adenine/analogs & derivatives, Aged, Antineoplastic Agents/therapeutic use, Datasets as Topic/statistics & numerical data, Female, Follow-Up Studies, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Middle Aged, Multicenter Studies as Topic, Piperidines/therapeutic use, Prognosis, Progression-Free Survival, Proportional Hazards Models, Protein Kinase Inhibitors/therapeutic use, Reproducibility of Results, Retrospective Studies, Risk Assessment, Severity of Illness Index, Survival Analysis",

author = "Fortunato Morabito and Giovanni Tripepi and {Del Poeta}, Giovanni and Mauro, {Francesca Romana} and Gianluigi Reda and Paolo Sportoletti and Luca Laurenti and Marta Coscia and Yair Herishanu and Marzia Varettoni and Roberta Murru and Annalisa Chiarenza and Andrea Visentin and Adalgisa Condoluci and Riccardo Moia and Daniela Pietrasanta and Giacomo Loseto and Ugo Consoli and Ilaria Scortechini and Rossi, {Francesca Maria} and Antonella Zucchetto and Ernesto Vigna and Martino, {Enrica Antonia} and Francesco Mendicino and Cirino Botta and Daniele Caracciolo and Ramona Cassin and Graziella D'Arrigo and Sara Galimberti and Angela Rago and Ilaria Angeletti and Annalisa Biagi and {Del Giudice}, Ilaria and Riccardo Bomben and Antonino Neri and Gilberto Fronza and Giovanna Cutrona and Davide Rossi and {Di Raimondo}, Francesco and Antonio Cuneo and Gianluca Gaidano and Aaron Polliack and Livio Trentin and Robin Fo{\`a} and Manlio Ferrarini and Valter Gattei and Massimo Gentile",

year = "2021",

month = may,

day = "1",

doi = "10.1002/ajh.26127",

language = "English",

volume = "96",

pages = "E168--E171",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Assessment of the 4-factor score: retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

AU - Morabito, Fortunato

AU - Tripepi, Giovanni

AU - Del Poeta, Giovanni

AU - Mauro, Francesca Romana

AU - Reda, Gianluigi

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Coscia, Marta

AU - Herishanu, Yair

AU - Varettoni, Marzia

AU - Murru, Roberta

AU - Chiarenza, Annalisa

AU - Visentin, Andrea

AU - Condoluci, Adalgisa

AU - Moia, Riccardo

AU - Pietrasanta, Daniela

AU - Loseto, Giacomo

AU - Consoli, Ugo

AU - Scortechini, Ilaria

AU - Rossi, Francesca Maria

AU - Zucchetto, Antonella

AU - Vigna, Ernesto

AU - Martino, Enrica Antonia

AU - Mendicino, Francesco

AU - Botta, Cirino

AU - Caracciolo, Daniele

AU - Cassin, Ramona

AU - D'Arrigo, Graziella

AU - Galimberti, Sara

AU - Rago, Angela

AU - Angeletti, Ilaria

AU - Biagi, Annalisa

AU - Del Giudice, Ilaria

AU - Bomben, Riccardo

AU - Neri, Antonino

AU - Fronza, Gilberto

AU - Cutrona, Giovanna

AU - Rossi, Davide

AU - Di Raimondo, Francesco

AU - Cuneo, Antonio

AU - Gaidano, Gianluca

AU - Polliack, Aaron

AU - Trentin, Livio

AU - Foà, Robin

AU - Ferrarini, Manlio

AU - Gattei, Valter

AU - Gentile, Massimo

PY - 2021/5/1

Y1 - 2021/5/1

KW - Adenine/analogs & derivatives

KW - Aged

KW - Antineoplastic Agents/therapeutic use

KW - Datasets as Topic/statistics & numerical data

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy

KW - Male

KW - Middle Aged

KW - Multicenter Studies as Topic

KW - Piperidines/therapeutic use

KW - Prognosis

KW - Progression-Free Survival

KW - Proportional Hazards Models

KW - Protein Kinase Inhibitors/therapeutic use

KW - Reproducibility of Results

KW - Retrospective Studies

KW - Risk Assessment

KW - Severity of Illness Index

KW - Survival Analysis

U2 - 10.1002/ajh.26127

DO - 10.1002/ajh.26127

M3 - Article

C2 - 33580969

SN - 0361-8609

VL - 96

SP - E168-E171

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 5

ER -